Identification of Stage IIIC/IV EGFR-Mutated Non-Small Cell Lung Cancer Populations Sensitive to Targeted Therapy Based on a PET/CT Radiomics Risk Model

OBJECTIVES: This project aimed to construct an individualized PET/CT prognostic biomarker to accurately quantify the progression risk of patients with stage IIIC-IV epidermal growth factor receptor (EGFR)-mutated Non-small cell lung cancer (NSCLC) after first-line first and second generation EGFR- t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Dan, Du, Dongyang, Liu, Haiping, Lv, Jieqin, Cheng, You, Zhang, Hao, Lv, Wenbing, Wang, Shuxia, Lu, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593197/
https://www.ncbi.nlm.nih.gov/pubmed/34796106
http://dx.doi.org/10.3389/fonc.2021.721318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593197/
https://www.ncbi.nlm.nih.gov/pubmed/34796106
http://dx.doi.org/10.3389/fonc.2021.721318

Ejemplares similares